August 2025 – Celluma Light Therapy, a leader in award-winning LED technology, has been recognized with three major honors from Lipgloss & Aftershave’s 2025 Clinical Collective Awards. The annual awards spotlight excellence and innovation in the professional aesthetics industry, and this year, Celluma stood out across multiple categories.

Celluma was named Best Clinical Device Brand, further solidifying its reputation as a trusted partner for estheticians, dermatologists, and wellness professionals worldwide. Known for its innovative, science-backed devices, Celluma continues to set the gold standard for clinical LED light therapy solutions.

In addition, the new Celluma CONTOUR PLUS earned the award for Best Technological Breakthrough. FDA-cleared for body contouring, pain management, acne, aging skin, and hair restoration, the flexible and multi-panel device represents a new era of versatility and treatment efficiency in light-based therapies.

Rounding out the triple win, the Celluma RESTORE received recognition as Best Clinical Scalp Treatment. FDA-cleared for hair restoration, aging skin, and pain, the RESTORE brings a non-invasive, drug-free solution to men and women experiencing hair loss, addressing a critical need in both medical and aesthetic practices.

“These awards are a testament to our ongoing commitment to innovation and excellence in clinical light therapy,” said Brian Gable, Celluma Chief Marketing Officer. “We are honored to be recognized by Lipgloss & Aftershave and grateful to the professionals who continue to trust Celluma in their treatment rooms.”

The recognition marks yet another milestone for Celluma, whose devices are consistently celebrated for their effectiveness, versatility, and user-friendly design. With this triple win, Celluma continues to cement its position as the global leader in LED light therapy technology.

YOU MIGHT ALSO LIKE